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It is now well recognised that certain pharmaceutical products, particularly antibiotics and antivirals, can have low removal efficiencies in passing through the unit processes associated with a conventional sewage treatment works (STW) (Fick et al., 2007; Ternes and Joss, 2007).  Although tertiary treatment using activated carbon and/or ozonation has been demonstrated to have a satisfactory removal potential for the majority of antibiotics (Ternes and Joss, 2007), there appears to be much more contention about the tertiary removal efficiency of antivirals.  Bartels and von Tumpling (2008), Accinelli et al (2010) and Presse et al (2010) have argued that photolyisis and extended microbial degradation during activated sludge treatment over 30 days is capable of largely removing the Oseltamivir carboxylate (OC) metabolite of the Tamiflu® antiviral prodrug.   However, other studies have provided evidence suggesting a conservation of OC on passage through secondary and tertiary treatment phases (Slater et al., 2011; Soderstrom et al., 2010).  These studies allege that the poor removal efficiency is primarily a function of the destabilisation of the microbial community structure inhibiting biofilm flocculation (1μg L-1 causing a 0.6-fold  inhibition).  In addition, the presence of a complex mixture of pharmaceutical species leads to interaction which exhibit concentration additivity (Soong et al., 2009; Slater et al., 2011).  Other workers have noted disruption to the nitrification process as well as bacterial community structure during and after high OC dosing (Parker et al., 2009).  As much as 50% of the antibiotics and antivirals will also accumulate in treated sludge, so there is also the potential for re-introduction into the environment.  Mass balance approaches are difficult as the pharmaceutical compounds can transform into unmeasured products and conjugates that pass through the STW.  As a potential emerging priority pollutant group, all pharmaceutical compounds including antivirals, are receiving more attention in terms of their potential toxicity to receiving water aquatic life and biota.

There have also been contradictory conclusions regarding the risk exposure in receiving waters of antiviral releases in discharges from STWs.  The majority of work would suggest that no significant risks are evident from analysis of predicted average environmental concentrations (Straub, 2009; Ellis, 2010) due to high dilution ratios available in most urban receiving waters.  Nevertheless, most workers have agreed that there remains considerable uncertainty associated with the risk evaluation methodologies which are compounded by the possibilities of long term chronic toxicity affects from persistent episodic combined sewer overflow (CSO) discharges and inoculation of benthal sediments (Ellis, 2009).  In addition, there is only very limited experience of the effectiveness of STW unit processes under elevated antiviral concentrations (≥350ng L-1) as well as untested management planning within wastewater systems when exposed to catastrophic pandemic conditions.  The paper will examine a pandemic preparedness planning approach for the wastewater sector in terms of essential processes, functions and system services as well as a risk assessment procedure for receiving water exposure.  


Wastewater System Management Under Pandemic Conditions

Organisation and structure. 














Figure 1.  Pandemic Organisational Response Structure

The public are in general less sensitive to threats directed at the wastewater system as compared to drinking water supplies, whilst regulatory agencies have been primarily concerned with receiving water impacts of STW service deficiencies and outages.  The principal strategic pandemic concerns for the wastewater sector are likely to focus on the treatment and removal efficiency in the treatment process of the Oseltamivir carboxylate (OC) metabolite of the prescribed dosing Tamiflu® pro-drug.  Variability in STW operation as well as the nature and timing of a pandemic will introduce considerable uncertainty on the likely scale of impact on the STW process.  If the influenza pandemic occurred as is most likely, during a cold winter period for example, the reduced temperatures would slow down microbial interactions and antiviral degradation rates which might prejudice the treatment process.  Wastewater performance risks may also be considerably exacerbated by worker absenteeism during pandemic conditions which might affect operational efficiency. Absentee levels of 15% - 20% at pandemic peaks have been predicted with illness periods lasting between 2 – 14 days.  In addition, there would be likely additional adverse “knock-on” impacts from absenteeism in inter-dependent public sectors such as power, transport, chemicals etc..

Wastewater System Management.  














Figure 2.   Extremis Risk Scaling for Wastewater Operations.

As a scaling base, a >1% case fatality ratio is used for predicting the likely severity of impact through the identification of trigger or threshold points and the scope of mitigation strategies and interventions at each operational level.  Such wastewater (and water) system preparedness planning is based on relatively simplistic pandemic impact assumptions including:
-	medical susceptibility will be universal with the disease spreading rapidly from source with multiple waves occurring, each lasting some 6 – 8 weeks.
-	clinical disease attack rates are likely to peak at 30% - 50% with absenteeism rates being in the order of 25% - 30%

Table 1 outlines a pandemic preparedness guidance scheme for the water sector which addresses primary actions identifying and assessing essential functions, processes and services.  Supporting actions prioritise services, equipment, materials, interdependencies and workforce requirements with further options and questions to be answered as part of the strategic and operational overview.   As far as the wastewater sector is concerned, it is not easy to see how some of the actions and tasks identified in Table 1 might be achieved.   It is not feasible for example, to “cut-off” sectors of the public sewer system even for temporary periods, although “hotspots” such as hospitals might be encouraged to install emergency storage facilities to provide an initial treatment for diverted sewage prior to onward conveyance to the STW.  However, the contribution of hospital antiviral input to overall wastewater load is generally less than 15% - 20%, thus the principal issue is with domestic effluent.  

Where hospital and other commercial wastes (care homes, offices etc.) are conveyed separately to the STW, it may also be possible to provide “individual” treatment if dedicated space is available; such interventions are costly and would require considerable early pre-pandemic planning.  In general however, the majority of STWs will have to deal with the total effluent process to identify how basic essential treatment can be maintained over critical peak pandemic periods when OC concentrations are likely to be at least 10-fold higher than currently occur in receiving waters.  These operational reviews must include consideration of the “no treatment” option and the likely impacts of “untreated” CSO discharges to receiving waterbodies.  Mitigation approaches might include how staged reductions in STW outflows could be achieved over short-term peak pandemic periods as well as through the introduction of national alternative vaccination campaigns.

Table 1.  Pandemic management of urban wastewater

STRATEGY	ACTION	SUPPORTING ACTIONS	QUESTIONS TO CONSIDER
Protect Essential Functions, Processes and Services	Identify and assess essential functions, processes and services	- identify essential processes and functions to maintain system performance- prioritise essential services and functions- identify non-essential functions that can be ssuspended- prioritise critical customers e.g  hospitals, ccare homes etc	- local stakeholders engaged in contingency planning?-  assess likely effect of reduced and no treatment options- essential business functions to be sustained?- staged reduction in service and functions as pandemic progresses?
Essential Equipment	Review equipment critical to support essential functions	-inventory of critical equipment-identify equipment that  must operate continuously and at key periods-identify primary and supporting components for single-point failures -identify cascading consequences	-can equipment and processes be modified to maintain essential functions?-how will pandemic affect demand on essential equipment?-operating procedures and contracts for emergency replacement and repair?
	Critical equipment for 6-12 weeks pandemic operation	-recurring, preventative  maintenance requirements-implications of equipment failure-prioritise options to reduce service demands	-capacity to reduce or alternate equipment usage-availability for equipment replacement/repair and emergency procurement procedures-deferral of scheduled maintenance
Essential Raw Materials & Supplies	Identify materials and supplies for essential functions	-identify critical inputs and supplies e.g coagulants etc.-assess internal and external supply chains-possibilities for stockpiling	-materials/supplies needed to maintain essential operations over pandemic wave period of 6 -8 weeks-possibilities for short-term product substitution-temporary plant modifications to reduce material/supply demands-reliability of supply chain
	Identify effective essential supply routes/chains	-stockpiling safety and security-ensure formal chain of command for ordering/repairs etc-coordination with supply chain vendors..	-“just-in-time” back-up plans-stockpiling costs-stockpiling delivery and space-purchasing arrangements e.g alternative use of credit cards
Essential Workforce	Identify critical process workforce	-identify critical workforce for essential functions-employee roles and responsibilities-impacts from essential worker absenteeism-employee communications-manual v automatic operations-family support plans for workforce	-identifying essential function workforce-operational challenges for critical workforce-external contractor support?-employment constraints eg. legal work hours etc..
Essential Inter-dependencies	Identify critical inter-dependent relationships	-assess external cross-sector essential services-coordination procedures with external agencies/networks to reduce operational vulnerabilities	-identify and prioritise cross-sectoral  dependencies in terms of critical operations-customer support and communication





There are considerable concerns over the resistance to elevated OC concentrations that might occur in receiving waters during and following a pandemic and the likely impact on the related ecosystem as well as the potential for the development of antibiotic resistant bacteria.  During the 2009 UK pandemic, studies of STWs discharging treated effluent to the River Thames in the Greater London region showed OC levels varying between 57 – 480ng L-1 (Soderstrom et al., 2010).  The maximum value detected is amongst the highest values for OC ever recorded in wastewater effluent.  In addition, the OC levels downstream of the receiving water mixing zone varied between 39 – 110ng L-1 which are broadly similar to levels that have been recorded in Japanese urban surface waters (Ghosh et al., 2010).  Singer et al (2011) have concluded that under severe pandemic conditions, all STWs in the Greater London region would be subject to microbial growth inhibition, with between 5% - 40% of downstream sections of the River Thames and tributaries exceeding threshold environmental toxicity. Such high levels question the validity of the minimal risk assessments for real pandemic conditions.

The European Agency for the Evaluation of Medicinal Products (EMEA, 2006) has developed a basic risk assessment procedure for predicting average annual concentrations for surface receiving waters (PECSW; mg L-1) based on a generic formula:
                                      PECSW  =  [Dd x Mp] / (Wvd x D) 
where Dd is the maximum daily dose (mg hd-1 d-1), Mp is market penetration (assumed to be 1% of population served), Wvd is the daily wastewater volume (L d-1) and D is the dilution factor assumed to be 10.  A variant of this EMEA model to derive the daily PECSW value under a pandemic situation based on the STW OC removal rate (STWr) can be expressed as:
                        PECSW  =  [(Dd x Infr x Ef) x (1 – STWr)] / [Wvd x D]
where Dd is expressed as the daily dose rate of active OC (assumed to be 75 mg twice a day), Infr the population infection rate, Ef the excreted fraction (0.8) of OC and P the population served by the STW.  This model was applied to the Thames Water Deephams STW in NE London, which has an average wastewater flow of 200 Ml d-1, serving a population of 836,000 and with a receiving water dilution capacity of 1.79.  Under an assumed 35% infection rate and an 80% OP/OC conversion rate, the calculated worst-case PECSW was equal to 20 μg L-1 over an estimated 8 – 10 week peak pandemic period.   This value is well below other modelling studies undertaken on the River Lea receiving water by Singer et al (2007 and 2008; 82 and 98 μg L-1)  respectively) and which are close to the 100µg L-1 threshold for daphnid and fish reproduction inhibition. Nevertheless, the modelling approaches would suggest that receiving water toxicity is unlikely and that ecosystem exposure risk is minimal. Although predicted values (20 -98 µg L-1 are considerably higher than monitored downstream concentrations (maximum 480 ng L-1)  

A variant of the EMEA risk assessment approach to predict the average daily OC concentration on the STW outflow can be expressed as:
                     PECSTW  =  [(TIC x Dd) x 0.7 x Ef x 1,000,000] / (P x Wu)
where TIC is the total number of infected cases per week and Wu is the per capita daily water usage (assumed to be 150L-1 hd-1 d-1).  Using an average 5% infection rate, this modelling approach derives a PECSTW value of 8µg L-1 but taking a higher 35% infection rate would derive a higher PECSTW value of 56µg L-1 and a predicted average receiving water concentration of 31µg L-1.  The EMEA risk assessment model can also be applied to calculate the OC receiving water sediment concentration and rates which vary between 0.006 – 0.228mg kg-1 for the Deephams STW as determined by Ellis (2010).  Such low mass loadings and associated bioaccumulation rates would suggest minimal chronic toxic risks to aquatic biota from accumulation and disturbance of weakly contaminated sediment.









Accinelli, C., Sacca, M.L., Fick, J., Mencarelli, M., Lindberg, R and Olsen, B.  2010. Dissipation and removal of Oseltamivir (Tamiflu®) in different aquatic environments,  Chemosphere,  79 (8), 891 – 897.
Bartels, P and von Tumpling, W. 2008.  The environmental fate of the antiviral drug Oseltamivir carboxylate in different waters.  Science Total Environ., 405, 215 – 225.
Ellis, J.B.  2009.  PPCP sources and pathways in the urban water cycle.  Proc. Int.Conf.Xenobiotics in the Urban Water Cycle; XENOWAC2009.  11-13 March 2009.  Cyprus.  ISBN 978 9963 671 892.
Ellis, J.B. 2010.  Antiviral pandemic risk assessment for urban receiving waters.  Water Sci & Tech., 61(4), 879-884.
EMEA.  2006.  Guidance on Environmental Risk Assessment of Medicinal Products for Human Use.  CHMP/SWP/4447100.  European Agency for the Evaluation of Medicinal Products(EMEA),  London.UK.
EPA. 2007. Pandemic Influenza: Preparedness, Response and Recovery. EPA 817-R-07-001. US Environmental Protection Agency, Office of Groundwater & Drinking Water, Security Division. Washington DC, US.
Fick, J., Lindberg, R.H., Tysklind, M., Haemig, P.D., Waldenstrom, J., Wallensten, A and Olsen, B.  2007  Antiviral Oseltamivir is not removed or degraded in normal sewage water treatment: Implications for development of resistance by Influenza A virus.   PLoS ONE, 2 (10), e986, 1-5.  (www.plosone.org (​http:​/​​/​www.plosone.org​)). 
Ghosh, G.C., Nakada, N., Yamashita, N and Tanaka, H.  2010.  Oseltamivir carboxylate: The active metabolite of Tamiflu® detected in sewage discharge and river water in Japan.  Envir. Heatlh Perspectives, 118(1), 103-107.
Parker, D., Soong, G., planet, P., Brower, J., Ratner, A.J and prince, A.  2009.  The NanA neuraminidase of Strepococcus pneumonia is involved in biofilm formation.  Infection & Immunity, 77(9), 3722 – 3730. 
Presse, C., Schlusenert, M.P., Schulz, R and Ternes, T.A.  2010.  Antiviral drugs in wastewater and surface waters: A new pharmaceutical class of environmental release.  Envir. Sci.Tech., 44(5), 1728 – 1735.
Singer, A.C., Nunn, M.A., Gould, E.A and Johnson, A.C.  2007.  Potential risks associated with the widespread use of Tamiflu®.  Environ. Health Perspectives.  115, 102 – 106.
Singer, A.C., Howard, B.M., Johnson, A.C., Knowles, C.J., Jackman, S., Accinelli, C.,Caracciolo, A.B., Bernard, I., Bird, S., Boucard, T., Boxall, A., Brian, J.V., Cartmell, E., Chubb, C., Churchley, J., Costigan, S., Crane, M., Dempsey, M.J., Dorrington, B., Ellor, B., Fick, J., Holmes, J., Hutchinson, T., Karcher, F., Kelleher, S.L., Marsden, P., Noone, G., Nunn, M.A., Oxford, J., Rachwal, T., Roberts, N., Roberts, M., Sacca, M.L., Sanders, M., Straub, J.O., Terry, A., Thomas, D., Toovey, S., Townsend, R., Vouivoulis, N and Watts, C.  2008.    Risk assessment of Tamiflu® use under pandemic conditions; Meeting report.  Environ. Health Perspectives, 116(11), 1563 – 1567.
Singer, A.C., Colizza, V., Schmitt, H., Andrews, J., Bolcan, D., Huang, W.E., Keller, V.D.J., Vespignani, A and Williams, R.J.  2011.  Assessing the ecotoxicological hazards of a pandemic influenza medical response. Environ. Health Perspectives.  Doi.10.1289/ehp.1002757.
Slater, F.R., Singer, A.C., Turner, S., Barr, J,J and Bond, P.L.  2011.  Pandemic pharmaceutical dosing effects on wastewater treatment.  FEMS Microbial Letters.  doi: 10.1111/j.1574-6968.2010.02163x.
Soderstrom, H., Jarhult, J.D., Fick, J., Lindberg, R., Singer, A.C., Grabic, R and Olsen, B.    2010. Levels of antivirals and antibiotics in the River Thames, UK during the 2009 pandemic  Proc. 19th Annual Meeting SETAC Europe: Protecting Ecosystem Health. 31 May – 4 June 2009. Gothenburg, Sweden.
Soong, G., Muir, A., Gomez, M.I., Waks, J., Reddy,B., Planet, P., Singh, P.K., Kanetko, Y., Wolfgang, M.S., Hsiao, Y.S., Tong, L and Prince, A.  2009.  Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production.  Journ.Clinical Investigation, 116(8), 2297 – 2305.
Straub, J.O. 2009.  An environmental risk assessment for Oseltamivir (Tamiflu®) for sewage works and surface waters under seasonal influenza and pandemic use conditions.  Ecotoxicology & Envir.Safety,  72. 1625 – 1634.
Ternes, T.A and Joss, A. (Edits).  2007.  Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management.  IWA Publishing, London.UK.  ISBN 978 1843390930.
































































Ellis and Revitt                                                                                                                      7                                                                  


